Podcast Library
Welcome to the Redox Revolution Podcast—your ultimate source for cutting-edge insights into cellular medicine, peptide therapy, and metabolic health.
Search Resources
Dr. Seeds opens up about his family tree in part one of a personal case study. He recounts his grandfather Elmore, a pioneer of nuclear medicine, and his father Asa, who helped establish maternal-fetal medicine, plus the habit of questioning everything that shaped his path into cellular medicine.
Veterinary epidemiologist Dr. Stephanie Venn-Watson recounts how studying Navy dolphins uncovered C15, or pentadecanoic acid, the first essential fatty acid identified in over 90 years. She and Dr. Seeds explore cellular fragility syndrome, how C15 strengthens cell membranes, and its roles in signaling, metabolism, and epigenetic regulation.
Methylene blue gets scrutinized as a redox-cycling agent that shuttles electrons past damaged complexes in the electron transport chain. Dr. Seeds defends its role in specific disease states while warning that its inhibition of nitric oxide and blocking of mitochondrial adaptation make it a poor choice for healthy people chasing performance.
NAD gets a hard look as Dr. Seeds challenges the booming infusion industry. He explains NAD's real role as a redox cofactor and sirtuin substrate, why CD38 sinks and senescent cells grab it first, and why the energy rush people feel is a false, catecholamine-driven signal rather than new ATP.
Is metformin really an anti-aging drug? Dr. Seeds pushes back on the longevity hype, noting the diabetes medication inhibits mitochondrial complex I, the very electron-transport machinery cellular medicine aims to strengthen. He examines the Horvath clock and telomere claims, and studies showing its mortality benefits may be short-lived.
Fiber is framed as the trigger for a cascade of molecular pathways rather than just a digestive aid. Dr. Seeds explains how gut microbes ferment indigestible fiber into short-chain fatty acids like butyrate, propionate and acetate that fuel colon cells, stimulate the body's own GLP-1 release, and support microbiome diversity and lipid metabolism.
Jason DiBona, CEO of Molekule, joins to examine how airborne pollutants damage health at the cellular level. The talk covers PM2.5 particulates crossing the lung barrier, oxidative stress and mitochondrial dysfunction, inflammaging, and why indoor air can be far dirtier than outdoor, making clean air a foundational part of any wellness routine.
Continuing the aesthetics conversation, Dr. Seeds explains what Botox actually does at the cellular level. Beyond legitimate uses for spasticity and migraines, cosmetic injections paralyze facial muscle, and the resulting disuse can drive atrophy, senescent cells, and fibrous tissue that complicate collagen health and later plastic surgery.
The extracellular matrix takes the spotlight as Dr. Seeds explains how BPC-157 and TB-500 support recovery, repair, and injury prevention at the cellular level. The episode also covers why static stretching before training can set you up for injury and makes the case for active, dynamic warmups.
Listener questions drive this AMA, opening with how people in their 30s can protect the cellular efficiency that begins declining with age. Dr. Seeds returns repeatedly to exercise as the master lever for sleep, mood, and metabolism, then unpacks calorie restriction, the four-day fast, and pairing secretagogue peptides with fasting.
Longtime friend and patient Nick Alexander, an elite Colorado ski instructor, joins Matt, Maddie and Dr. Seeds. Between stories of 24 years on the mountain, Nick describes the knee and back injuries that threatened his career and how peptides, stem cells and tissue-repair protocols kept him skiing when surgeons offered little hope.
Wearables like Whoop and Oura and the rise of AI in medicine anchor a conversation about data versus judgment. Dr. Seeds and the hosts weigh how trackers motivate patients while risking sensory overload, and discuss AI hallucinations, data privacy, algorithmic bias, and why technology should sharpen curiosity rather than replace a provider's foundational knowledge.
Peptides get a ground-up introduction as signaling agents the body already recognizes, built from amino acids joined by peptide bonds. Dr. Seeds explains how they nudge enzymes, receptors, and mitochondrial efficiency, and distinguishes cellular medicine from regenerative and functional medicine as the next step deeper into the cell.
Chronic disease takes hold when cells lose the ability to adapt to everyday stress. Dr. Seeds explains how redox imbalance and mitochondrial dysfunction drive conditions like metabolic syndrome, why static biomarker and biological-age tests can mislead patients, and why restoring the cellular environment matters more than chasing individual numbers.
Fitness coach Jay Ferruggia joins to challenge gym myths, from the fat-loss workout fallacy to chronic overtraining. He and Dr. Seeds make the case for performance-focused, low-fatigue training, prioritizing sleep and recovery, and treating muscle as a longevity organ, with peptides gaining ground in the strength community.
Reviewing 2024's standout peptides, Dr. Seeds crowns GLP-1 receptor agonists, tracing the progression from semaglutide to tirzepatide and triple-agonist retatrutide and their tolerability gains. He adds tesamorelin and growth-hormone secretagogues for mitochondrial and metabolic support, plus candid talk on compounding, dosing, and affordability.
Can cellular damage and aging be reversed? Dr. Seeds returns to the three pillars of exercise, diet and sleep, then explains how insulin resistance signals stressed beta cells and how peptides, GLP-1 agonists and circadian repair can restore mitochondrial flexibility and NAD production to help patients age more gracefully.
The inaugural episode lays the groundwork for the series, defining redox as the balance of oxidative stress and antioxidants that governs cellular health. Dr. Seeds explains how he used peptides, starting with insulin, to introduce physicians to cellular medicine, and why individualized thinking beats rigid protocols and marker-chasing lab panels.